/ ANGO
AngioDynamics Stock Drops 24% After Q2 Earnings Report
AngioDynamics reported Q2 FY24 with $81.97M in sales and revised annual guidance to $320-$325M amidst market challenges.
January 05, 2024AngioDynamics reported Q2 FY24 with $81.97M in sales and revised annual guidance to $320-$325M amidst market challenges.
January 05, 2024